MFG
AVNS

Mendota Financial Group’s Avanos Medical AVNS Stock Holding History

Mendota Financial Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8
Closed -$193 – 449
2024
Q3 		$193 Buy
+8
New +$183 ﹤0.01% 645

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Mendota Financial Group's AVNS Position: Q4 2024 in Review

Mendota Financial Group sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 8 shares — an estimated $193 sold.

Mendota Financial Group first reported a position in AVNS in Q3 2024 and held it in 1 quarter. The position peaked at $193 in Q3 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Mendota Financial Group reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Mendota Financial Group sold 8 Avanos Medical shares in Q4 2024, an estimated $193.
  • Mendota Financial Group first reported a position in Avanos Medical in Q3 2024 and held it in 1 quarter.
  • Mendota Financial Group's Avanos Medical position peaked at $193 in Q3 2024.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.